CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-09 | Levy Howard Chief Medical Officer | Purchase | +639 | $3.62 | $2K | 639 |
| 2021-02-09 | Levy Howard Chief Medical Officer | Purchase | +1,670 | $4.81 | $8K | 23,390 |
| 2021-02-08 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-08 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-08-10 | Levy Howard Chief Medical Officer | Purchase | +1,768 | $4.81 | $9K | 4,268 |
| 2020-03-16 | Levy Howard Chief Medical Officer | Purchase | +2,500 | $4.05 | $10K | 2,500 |
| 2020-02-10 | Levy Howard Chief Medical Officer | Grant or award | +1,358 | $6.23 | $8K | 1,358 |
| 2020-01-23 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 |
Page 1 of 1 · 8 trades